Cancer Biomarkers Market is Forecast to Reach US$27.63 Billion by 2025; Rising Focus on Personalized Medicine to Accelerate Growth - TMR

News provided by

Sep 14, 2018, 06:30 ET

ALBANY, New York, September 14, 2018 /PRNewswire/ --

The global cancer biomarkers market has been growing at a fast pace, owing to the research and development activities. The developing economies hold promising growth opportunities for the market players, which is likely to accelerate the growth of the market in the near future. According to the market research study by Transparency Market Research, the global cancer biomarkers market is predicted to register a strong 11.80% CAGR between 2017 and 2025.

(Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=479

The major factors that are encouraging the growth of the global cancer biomarkers market have been mentioned below:

The rising incidence of cancer and the growing focus on technological advancements are the key factors that are projected to accelerate the growth of the global cancer biomarkers market in the next few years.
The rising use of cancer biomarkers in drug development and discovery is another major factor, which is estimated to enhance the growth of the cancer biomarkers market in the coming few years.
The increasing focus of key players on the research and development activities is expected to create potential growth opportunities in the next few years, thus accelerate the growth of the overall market in the near future.
In addition to this, the increasing focus on personalized medicine and companion diagnostics are likely to enhance the growth of the cancer biomarkers market across the globe.

Request a Sample of Cancer Biomarkers Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=479

Rising Prevalence of Cancer to Drive North America and Asia Pacific Market

The global market for cancer biomarkers has been categorized on the basis of geography into the Middle East and Africa, Europe, Asia Pacific, North America, and Latin America. Among these segments, North America is anticipated to account for a large share of the global cancer biomarkers and register a healthy growth rate in the next few years. The strong growth of this region can be attributed to the rising prevalence of cancer and the development of the healthcare services. In addition to this, the growing demand for enhanced diagnostic tests and healthcare services are some of the other key factors that are predicted to accelerate the growth of the North America cancer biomarkers market in the next few years.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=479

Furthermore, the Asia Pacific market for cancer biomarkers is projected to register a healthy growth rate in the next few years. The presence of a large patient pool and the rising awareness among people regarding the maintenance of good health are some of the key factors that are projected to accelerate the growth of the market across Asia Pacific in the next few years. Moreover, the rising geriatric population and the rising disposable income of consumers are further estimated to accelerate the market growth in the near future.

Browse Press Release: https://www.transparencymarketresearch.com/pressrelease/cancer-biomarkers-market.htm

Rising Focus on Research and Development Activities to Enhance Market Growth

The global market for cancer biomarkers is extremely competitive in nature and is projected to witness a stiff competition among the leading players in the next few years. The rising investments for research and development activities and the increasing focus of key players on innovations and advancements are some of the key factors that are projected to enhance the growth of the global cancer biomarkers market in the next few years. Some of the leading players operating in the cancer biomarkers market across the globe are QIAGEN, Agilent Technologies, bioMérieux SA, F. Hoffmann-La Roche Ltd, Illumina, Inc., Hologic, Inc., Genomic Health, Inc., Merck & Co., Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., and Novartis AG.

Popular Research Reports by TMR:

Tumor Ablation Market: https://www.transparencymarketresearch.com/tumor-ablation-market.html
Prostate Cancer Therapeutics Market: https://www.transparencymarketresearch.com/prostate-cancer-therapeutics-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]